Brettschneider Christian, Bleibler Florian, Hiller Thomas S, Konnopka Alexander, Breitbart Jörg, Margraf Jürgen, Gensichen Jochen, König Hans-Helmut
1Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
2Institute of General Practice & Family Medicine, Jena University Hospital, Friedrich-Schiller-University, Bachstrasse 18, 07743 Jena, Germany.
Cost Eff Resour Alloc. 2019 Apr 27;17:9. doi: 10.1186/s12962-019-0177-4. eCollection 2019.
Panic disorder is a mental disorder of high prevalence, which frequently co-occurs with agoraphobia. There is a lack of studies measuring excess costs of panic disorder patients with and without agoraphobia. We compared costs of panic disorder patients with or without agoraphobia with costs of the anxiety-free population in Germany.
Primary data from a cluster-randomized trial of adults suffering from panic disorder (n = 419) and from a representative survey of the German general population (N = 5005) were collected between 2012 and 2014. Missing data from the cluster-randomized trial were first imputed by multiple imputation using chained equations and subsequently balanced with the data from the survey by Entropy Balancing. The societal perspective was chosen. Excess costs were calculated by generalized linear models and two-part-models.
Entropy Balancing led to an exact match between the groups. We found 6-month total excess costs of 3220€ (95% CI 1917€-4522€) for panic disorder patients without agoraphobia and of 3943€ (95% CI 2950€-4936€) for patient with agoraphobia. Panic disorder patients with or without agoraphobia had significantly higher costs for psychotherapy, general practitioners, general hospital stays and informal care Indirect costs accounted for approximately 60% of the total excess costs.
Panic disorder with or without agoraphobia is associated with significant excess costs. Agoraphobia changes the pattern of resource utilization. Especially indirect costs are relevant. Agoraphobia influences resource utilization in the inpatient sector. ISRCTN64669297.
惊恐障碍是一种高发性精神障碍,常与广场恐惧症并发。目前缺乏对伴有或不伴有广场恐惧症的惊恐障碍患者额外费用的研究。我们将伴有或不伴有广场恐惧症的惊恐障碍患者的费用与德国无焦虑人群的费用进行了比较。
2012年至2014年期间收集了来自一项针对惊恐障碍成年人的整群随机试验(n = 419)的原始数据以及来自德国普通人群的代表性调查(N = 5005)的数据。整群随机试验中的缺失数据首先使用链式方程通过多重插补进行估算,随后通过熵平衡与调查数据进行平衡。选择了社会视角。通过广义线性模型和两部分模型计算额外费用。
熵平衡导致各组之间完全匹配。我们发现,不伴有广场恐惧症的惊恐障碍患者6个月的总额外费用为3220欧元(95%置信区间1917欧元 - 4522欧元),伴有广场恐惧症的患者为3943欧元(95%置信区间2950欧元 - 4936欧元)。伴有或不伴有广场恐惧症的惊恐障碍患者在心理治疗、全科医生、综合医院住院和非正式护理方面的费用显著更高。间接费用约占总额外费用的60%。
伴有或不伴有广场恐惧症的惊恐障碍都与显著的额外费用相关。广场恐惧症改变了资源利用模式。特别是间接费用很重要。广场恐惧症影响住院部门的资源利用。ISRCTN64669297。